BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

861 related articles for article (PubMed ID: 28735160)

  • 21. Effectiveness of multiple botulinum toxin sessions and the duration of effects in spasticity therapy in children with cerebral palsy.
    Mirska A; Kułak W; Okurowska-Zawada B; Dmitruk E
    Childs Nerv Syst; 2019 Jan; 35(1):141-147. PubMed ID: 30058050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treating spastic equinus foot from cerebral palsy with botulinum toxin type A: what factors influence the results?: an analysis of 189 consecutive cases.
    Pascual-Pascual SI; Pascual-Castroviejo I; Ruiz PJ
    Am J Phys Med Rehabil; 2011 Jul; 90(7):554-63. PubMed ID: 21765274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity induced by botulinum toxin injections for limb spasticity: A systematic review.
    Mathevon L; Declemy A; Laffont I; Perennou D
    Ann Phys Rehabil Med; 2019 Jul; 62(4):241-251. PubMed ID: 30980953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of serial injections of botulinum toxin A in children with spastic cerebral palsy.
    Wang YJ; Gao BQ
    World J Pediatr; 2013 Nov; 9(4):342-5. PubMed ID: 24235067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
    Wasiak J; Hoare B; Wallen M
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003469. PubMed ID: 15495055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Casting Protocols Following BoNT-A Injections to Treat Spastic Hypertonia of the Triceps Surae in Children with Cerebral Palsy and Equinus Gait: A Randomized Controlled Trial.
    Kelly B; MacKay-Lyons M; Berryman S; Hyndman J; Wood E
    Phys Occup Ther Pediatr; 2019; 39(1):77-93. PubMed ID: 29771161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is botulinum toxin type A more effective and safer than other treatments for the management of lower limb spasticity in children with cerebral palsy? A Cochrane Review summary with commentary.
    Kim H; Kolaski K
    NeuroRehabilitation; 2021; 49(1):161-164. PubMed ID: 34366300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional outcomes following ultrasound-guided botulinum toxin type A injections to reduce spastic equinovarus in adult post-stroke patients.
    Aktürk S; Büyükavcı R; Ersoy Y
    Toxicon; 2018 May; 146():95-98. PubMed ID: 29530514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Short-Term Impact of Botulinum Neurotoxin-A on Muscle Morphology and Gait in Children with Spastic Cerebral Palsy.
    Peeters N; Papageorgiou E; Hanssen B; De Beukelaer N; Staut L; Degelaen M; Van den Broeck C; Calders P; Feys H; Van Campenhout A; Desloovere K
    Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of botulinum toxin injections on gait control in spastic stroke patients presenting with a stiff-knee gait.
    Bleyenheuft C; Cockx S; Caty G; Stoquart G; Lejeune T; Detrembleur C
    Gait Posture; 2009 Aug; 30(2):168-72. PubMed ID: 19442523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke.
    Santamato A; Cinone N; Panza F; Letizia S; Santoro L; Lozupone M; Daniele A; Picelli A; Baricich A; Intiso D; Ranieri M
    Drugs; 2019 Feb; 79(2):143-160. PubMed ID: 30623347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Muscle volume alterations in spastic muscles immediately following botulinum toxin type-A treatment in children with cerebral palsy.
    Williams SA; Reid S; Elliott C; Shipman P; Valentine J
    Dev Med Child Neurol; 2013 Sep; 55(9):813-20. PubMed ID: 23789782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The utility of shear wave elastography in the evaluation of muscle stiffness in patients with cerebral palsy after botulinum toxin A injection.
    Dağ N; Cerit MN; Şendur HN; Zinnuroğlu M; Muşmal BN; Cindil E; Oktar SÖ
    J Med Ultrason (2001); 2020 Oct; 47(4):609-615. PubMed ID: 32705628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medial gastrocnemius volume and echo-intensity after botulinum neurotoxin A interventions in children with spastic cerebral palsy.
    Schless SH; Cenni F; Bar-On L; Hanssen B; Kalkman B; O'brien T; Aertbeliën E; Van Campenhout A; Molenaers G; Desloovere K
    Dev Med Child Neurol; 2019 Jul; 61(7):783-790. PubMed ID: 30320442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of botulinum toxin type A treatment in children with cerebral palsy: Sequential physical changes for 3 months after the injection.
    Matsuda M; Tomita K; Yozu A; Nakayama T; Nakayama J; Ohguro H; Iwasaki N
    Brain Dev; 2018 Jun; 40(6):452-457. PubMed ID: 29510955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke.
    Pittock SJ; Moore AP; Hardiman O; Ehler E; Kovac M; Bojakowski J; Al Khawaja I; Brozman M; Kanovský P; Skorometz A; Slawek J; Reichel G; Stenner A; Timerbaeva S; Stelmasiak Z; Zifko UA; Bhakta B; Coxon E
    Cerebrovasc Dis; 2003; 15(4):289-300. PubMed ID: 12686794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrasonographic evaluation of changes in the muscle architecture of the gastrocnemius with botulinum toxin treatment for lower extremity spasticity in children with cerebral palsy.
    Kawano A; Yanagizono T; Kadouchi I; Umezaki T; Chosa E
    J Orthop Sci; 2018 Mar; 23(2):389-393. PubMed ID: 29146092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-Term Effects of Botulinum Toxin-A Injection on the Medial Gastrocnemius Histological Features in Ambulant Children with Cerebral Palsy: A Longitudinal Pilot Study.
    Deschrevel J; Andries A; Maes K; De Beukelaer N; Corvelyn M; Staut L; De Houwer H; Costamagna D; Desloovere K; Van Campenhout A; Gayan-Ramirez G
    Toxins (Basel); 2024 Jan; 16(2):. PubMed ID: 38393147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Motor endplate-targeted botulinum toxin injections of the gracilis muscle in children with cerebral palsy.
    Van Campenhout A; Bar-On L; Desloovere K; Huenaerts C; Molenaers G
    Dev Med Child Neurol; 2015 May; 57(5):476-83. PubMed ID: 25557985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin a injection into calf muscles for treatment of spastic equinus in cerebral palsy: a controlled trial comparing sonography and electric stimulation-guided injection techniques: a preliminary report.
    Kwon JY; Hwang JH; Kim JS
    Am J Phys Med Rehabil; 2010 Apr; 89(4):279-86. PubMed ID: 20068435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.